Q5ZPR3 (CD276_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 86.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: CD276 antigen Alternative name(s): 4Ig-B7-H3 B7 homolog 3 Short name=B7-H3 Costimulatory molecule CD_antigen=CD276 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 534 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May participate in the regulation of T-cell-mediated immune response. May play a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. May be involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. Could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy. Both isoform 1 and isoform 2 appear to be redundant in their ability to modulate CD4 T-cell responses. Isoform 2 is shown to enhance the induction of cytotoxic T-cells and selectively stimulates interferon gamma production in the presence of T-cell receptor signaling. Ref.1 Ref.2 Ref.8 Ref.9 Ref.11 Ref.13 |
| Subunit structure | Interacts with TREML2 and this interaction enhances T-cell activation. Ref.14 |
| Subcellular location | Membrane; Single-pass type I membrane protein Probable. |
| Tissue specificity | Ubiquitous but not detectable in peripheral blood lymphocytes or granulocytes. Weakly expressed in resting monocytes. Expressed in dendritic cells derived from monocytes. Expressed in epithelial cells of sinonasal tissue. Expressed in extravillous trophoblast cells and Hofbauer cells of the first trimester placenta and term placenta. Ref.1 Ref.2 Ref.10 Ref.11 Ref.12 |
| Induction | By bacterial lipopolysaccharides (LPS) in monocytes and by ionomycin in T and B-lymphocytes. Up-regulated in cells mediating rejection of human transplants. Ref.2 Ref.13 |
| Miscellaneous | B7-H3 locus underwent genomic duplication leading to tandemly repeated immunoglobulin-like V and C domains (VC domains). The dominantly expressed human B7-H3 isoform contains tandemly duplicated VC domains. In contrast, mouse B7-H3 transcript contains only one single VC domain form due to an exon structure corresponding to V domain-(pseudoexon C)-(pseudoexon V)-C domain. This duplication appearing in primates is suggested to be very recent supporting a model of multiple independent emergence of tandem VC repeats within human and monkey species. |
| Sequence similarities | Belongs to the immunoglobulin superfamily. BTN/MOG family. Contains 2 Ig-like C2-type (immunoglobulin-like) domains. Contains 2 Ig-like V-type (immunoglobulin-like) domains. |
| Sequence caution | The sequence BAC11344.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q5ZPR3-1) Also known as: 4Ig-B7-H3; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Contains tandemly repeated immunoglobulin-like V and C domains. | ||||||
| Isoform 2 (identifier: Q5ZPR3-2) Also known as: B7-H3; The sequence of this isoform differs from the canonical sequence as follows: 159-376: Missing. | ||||||
| Note: Minor transcript. Contains one single set of immunoglobulin-like V and C domains. | ||||||
| Isoform 3 (identifier: Q5ZPR3-3) The sequence of this isoform differs from the canonical sequence as follows: 465-493: EALWVTVGLSVCLIALLVALAFVCWRKIK → GPASSAVPLSPAHPPHGSMCWSHWFSRGL 494-534: Missing. | ||||||
| Note: Contains tandemly repeated immunoglobulin-like V and C domains. | ||||||
| Isoform 4 (identifier: Q5ZPR3-4) The sequence of this isoform differs from the canonical sequence as follows: 528-534: DDGQEIA → GKDTWA | ||||||
| Note: Contains tandemly repeated immunoglobulin-like V and C domains. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | Ref.7 | ||||||||
| Chain | 29 – 534 | 506 | CD276 antigen | PRO_0000045801 | |||||||
Regions | |||||||||||
| Topological domain | 29 – 466 | 438 | Extracellular Potential | ||||||||
| Transmembrane | 467 – 487 | 21 | Helical; Potential | ||||||||
| Topological domain | 488 – 534 | 47 | Cytoplasmic Potential | ||||||||
| Domain | 29 – 139 | 111 | Ig-like V-type 1 | ||||||||
| Domain | 145 – 238 | 94 | Ig-like C2-type 1 | ||||||||
| Domain | 243 – 357 | 115 | Ig-like V-type 2 | ||||||||
| Domain | 363 – 456 | 94 | Ig-like C2-type 2 | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 525 | 1 | Phosphoserine Ref.16 | ||||||||
| Glycosylation | 104 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 189 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 215 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 322 | 1 | N-linked (GlcNAc...) Ref.17 | ||||||||
| Glycosylation | 407 | 1 | N-linked (GlcNAc...) Ref.17 | ||||||||
| Glycosylation | 433 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 50 ↔ 122 | By similarity | |||||||||
| Disulfide bond | 165 ↔ 220 | By similarity | |||||||||
| Disulfide bond | 268 ↔ 340 | By similarity | |||||||||
| Disulfide bond | 383 ↔ 438 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 159 – 376 | 218 | Missing in isoform 2. | VSP_017088 | |||||||
| Alternative sequence | 465 – 493 | 29 | EALWV…WRKIK → GPASSAVPLSPAHPPHGSMC WSHWFSRGL in isoform 3. | VSP_017089 | |||||||
| Alternative sequence | 494 – 534 | 41 | Missing in isoform 3. | VSP_017090 | |||||||
| Alternative sequence | 528 – 534 | 7 | DDGQEIA → GKDTWA in isoform 4. | VSP_017091 | |||||||
| Natural variant | 97 | 1 | P → L. Corresponds to variant rs7173448 [ dbSNP | Ensembl ]. | VAR_049857 | |||||||
| Natural variant | 111 | 1 | R → S. Corresponds to variant rs7173476 [ dbSNP | Ensembl ]. | VAR_049858 | |||||||
| Natural variant | 137 | 1 | Q → L. Corresponds to variant rs11574477 [ dbSNP | Ensembl ]. | VAR_049859 | |||||||
| Natural variant | 160 | 1 | T → M. Ref.4 Ref.5 Corresponds to variant rs11574479 [ dbSNP | Ensembl ]. | VAR_049860 | |||||||
| Natural variant | 267 | 1 | R → H. Corresponds to variant rs11574483 [ dbSNP | Ensembl ]. | VAR_049861 | |||||||
| Natural variant | 279 | 1 | A → T. Corresponds to variant rs10083681 [ dbSNP | Ensembl ]. | VAR_049862 | |||||||
| Natural variant | 315 | 1 | P → L. Corresponds to variant rs7173448 [ dbSNP | Ensembl ]. | VAR_049863 | |||||||
| Natural variant | 329 | 1 | R → S. Corresponds to variant rs7173476 [ dbSNP | Ensembl ]. | VAR_049864 | |||||||
| Natural variant | 378 | 1 | T → M. Corresponds to variant rs11574479 [ dbSNP | Ensembl ]. | VAR_049865 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 387 | 1 | R → Q in AAQ88709. Ref.3 | ||||||||
| Sequence conflict | 473 | 1 | L → P in BAC11243. Ref.4 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production." Chapoval A.I., Ni J., Lau J.S., Wilcox R.A., Flies D.B., Liu D., Dong H., Sica G.L., Zhu G., Tamada K., Chen L. Nat. Immunol. 2:269-274(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, FUNCTION. |
| [2] | "Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains." Steinberger P., Majdic O., Derdak S.V., Pfistershammer K., Kirchberger S., Klauser C., Zlabinger G., Pickl W.F., Stockl J., Knapp W. J. Immunol. 172:2352-2359(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, FUNCTION, INDUCTION. |
| [3] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 91-534 (ISOFORM 1), VARIANT MET-160. |
| [5] | "Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries." Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J., Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S., Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y. Isogai T.DNA Res. 12:117-126(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT MET-160. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Lung. |
| [7] | "Signal peptide prediction based on analysis of experimentally verified cleavage sites." Zhang Z., Henzel W.J. Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 29-43. |
| [8] | "Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss." Ling V., Wu P.W., Spaulding V., Kieleczawa J., Luxenberg D., Carreno B.M., Collins M. Genomics 82:365-377(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, GENOMIC DOMAIN DUPLICATION. |
| [9] | "Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis." Castriconi R., Dondero A., Augugliaro R., Cantoni C., Carnemolla B., Sementa A.R., Negri F., Conte R., Corrias M.V., Moretta L., Moretta A., Bottino C. Proc. Natl. Acad. Sci. U.S.A. 101:12640-12645(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta." Petroff M.G., Kharatyan E., Torry D.S., Holets L. Am. J. Pathol. 167:465-473(2005) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [11] | "Constitutive and inducible expression of B7 family of ligands by human airway epithelial cells." Kim J., Myers A.C., Chen L., Pardoll D.M., Truong-Tran Q.A., Lane A.P., McDyer J.F., Fortuno L., Schleimer R.P. Am. J. Respir. Cell Mol. Biol. 33:280-289(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [12] | "B7-H3: another molecule marker for Mo-DCs?" Zhang G.B., Dong Q.M., Xu Y., Yu G.H., Zhang X.G. Cell. Mol. Immunol. 2:307-311(2005) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [13] | "B7-H3 promotes acute and chronic allograft rejection." Wang L., Fraser C.C., Kikly K., Wells A.D., Han R., Coyle A.J., Chen L., Hancock W.W. Eur. J. Immunol. 35:428-438(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INDUCTION. |
| [14] | "Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses." Hashiguchi M., Kobori H., Ritprajak P., Kamimura Y., Kozono H., Azuma M. Proc. Natl. Acad. Sci. U.S.A. 105:10495-10500(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TREML2. |
| [15] | Erratum Hashiguchi M., Kobori H., Ritprajak P., Kamimura Y., Kozono H., Azuma M. Proc. Natl. Acad. Sci. U.S.A. 105:14744-14744(2008) |
| [16] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-525, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-322 AND ASN-407, MASS SPECTROMETRY. Tissue: Liver. |
| [18] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF302102 mRNA. Translation: AAK15438.1. AJ583695 mRNA. Translation: CAE47548.1. AY358343 mRNA. Translation: AAQ88709.1. AK074849 mRNA. Translation: BAC11243.1. AK074997 mRNA. Translation: BAC11344.1. Different initiation. AK075549 mRNA. Translation: BAC11692.1. BC062581 mRNA. Translation: AAH62581.1. |
| IPI | IPI00019275. IPI00410488. IPI00441094. IPI00719044. |
| RefSeq | NP_001019907.1. NM_001024736.1. NP_079516.1. NM_025240.2. |
| UniGene | Hs.77873. |
3D structure databases | |
| ProteinModelPortal | Q5ZPR3. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q5ZPR3. 1 interaction. |
| MINT | MINT-5000152. |
| STRING | 9606.ENSP00000320084. |
PTM databases | |
| PhosphoSite | Q5ZPR3. |
Polymorphism databases | |
| DMDM | 74757248. |
Proteomic databases | |
| PaxDb | Q5ZPR3. |
| PRIDE | Q5ZPR3. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000318424; ENSP00000320058; ENSG00000103855. ENST00000318443; ENSP00000320084; ENSG00000103855. ENST00000537340; ENSP00000441087; ENSG00000103855. ENST00000561213; ENSP00000452736; ENSG00000103855. ENST00000564751; ENSP00000454940; ENSG00000103855. |
| GeneID | 80381. |
| KEGG | hsa:80381. |
| UCSC | uc002avu.1. human. uc002avv.1. human. uc002avw.1. human. |
Organism-specific databases | |
| CTD | 80381. |
| GeneCards | GC15P073976. |
| HGNC | HGNC:19137. CD276. |
| HPA | CAB017826. HPA009285. HPA017139. |
| MIM | 605715. gene. |
| neXtProt | NX_Q5ZPR3. |
| PharmGKB | PA142672148. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG85729. |
| HOVERGEN | HBG079786. |
| InParanoid | Q5ZPR3. |
| KO | K06746. |
| OMA | GALWFCL. |
Gene expression databases | |
| ArrayExpress | Q5ZPR3. |
| Bgee | Q5ZPR3. |
| CleanEx | HS_CD276. |
| Genevestigator | Q5ZPR3. |
| GermOnline | ENSG00000103855. Homo sapiens. |
Family and domain databases | |
| Gene3D | 2.60.40.10. 4 hits. |
| InterPro | IPR013162. CD80_C2-set. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR003598. Ig_sub2. IPR013106. Ig_V-set. [Graphical view] |
| Pfam | PF08205. C2-set_2. 2 hits. PF07686. V-set. 2 hits. [Graphical view] |
| SMART | SM00409. IG. 3 hits. SM00408. IGc2. 1 hit. [Graphical view] |
| PROSITE | PS50835. IG_LIKE. 4 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 80381. |
| NextBio | 70980. |
| SOURCE | Search... |
Entry information
| Entry name | CD276_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q5ZPR3 Secondary accession number(s): Q6P5Y4 Q9BXR1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 15 Human chromosome 15: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
